DCI APP Chemotherapy Prescribing Lecture Series 2025 (Enduring)
In support of improving patient care, Duke University Health System Clinical Education and Professional Development is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the health care team. The designation was based upon the quality of the educational activity and its compliance with the standards and policies of the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC).

Program Description: DCI APP Chemotherapy Prescribing Lecture Series 2025 (Enduring) Core requirements for qualification to prescribe chemotherapy for advances practice providers and clinical pharmacists' providers.
Target Audience
Nurse Practitioners
Physician Assistants
Pharmacists
Physicians
Learning Objectives
Understand the drug classes of chemotherapy Understand dose reduction. Understand supportive care for patients receiving chemotherapy Understand side effects and treatment related to immunotherapy Learn about new drug therapy
Edwin Alyea, M.D.
Meredith Moorman, PharmD, BCOP, CPP
Therese M. Hennig, PA-C, MPAS
ACPE - Pharmacist
AMA PRA Category 1 Credit(s)
ANCC
JA Credit - AH

Facebook
X
LinkedIn
Forward